Clinical Trial Update: Incretin Microdosing for Cardiometabolic Health in People With HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating incretin microdosing to improve cardiometabolic health in people living with HIV. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Weight Gain | Phase 2 | Status: RECRUITING